Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Renovaro Inc
Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
June 03, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
May 22, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
POAI
RENB
Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
May 22, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
POAI
RENB
Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform
May 14, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics
May 13, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs
April 22, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
April 09, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
April 04, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
POAI
RENB
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
March 03, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
POAI
RENB
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
February 26, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Announces $15 million in Equity Committed
February 26, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Appoints Nathen Fuentes as Chief Financial Officer
January 07, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Issues Shareholder Letter and Provides Corporate Update
January 07, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
POAI
RENB
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
January 06, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
POAI
RENB
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
December 30, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program
December 23, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Regains Compliance with NASDAQ Listing Requirement
December 20, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection
December 20, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Issues Shareholder Letter and Provides Corporate Update
November 04, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
October 17, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Announces Strategic Restructuring and Leadership Transition
October 16, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics
September 19, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
September 17, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
September 13, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
RenovaroCube Announces Strategic Offering of Up to 20% Ownership
September 11, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro, Inc. Announces $10 million in Equity Committed
June 14, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
May 24, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
April 30, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
April 24, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit